Certified Recovery Specialist - Columbia, SC

Certified Recovery Specialist - Columbia, SC

Join Crossroads as a Certified Recovery Specialist in Columbia, SC.

Crossroads Treatment Centers is an equal opportunity employer. We celebrate diversity and are committed to creating an inclusive environment for all employees.

Since 2005, Crossroads has been at the forefront of treating patients with opioid use disorder. Crossroads is a family of professionals dedicated to providing the most accessible, highest quality, evidence-based medication assisted treatment (MAT) options to combat the growing opioid epidemic and helping people with opioid use disorder start their path to recovery.

Day in the Life of a Certified Recovery Specialist

• Provide peer-based recovery support services to individuals contemplating or actively seeking help with behavioral health recovery.
• Collaborate with county jails, detention centers, and drug courts to connect individuals to medication-assisted treatment (MAT) both pre-trial and post-adjudication.
• Host community events to distribute harm reduction materials and collaborate with key community partners, including justice-involved partners.
• Engage in relationship building with individuals to establish rapport, as evidenced by empathetic and active listening and communicating in a non-judgmental way.
• Participate in daily shift debriefs, as well as weekly individual supervision, and monthly group supervision.
• Administrative duties to include recovery plan creation, data tracking and entry, and regular digital communication via e-mail, group messaging apps, etc.
• Conduct self in an ethical manner by adhering to the TCBAP codes of ethics.
• Follow and adhere to the recovery bill of rights.

Education And Experience Requirements

Schedule

Must be available as early as 4 : 45am, evening and weekends. Specific scheduling will be discussed with recruiting and hiring manager.

Benefits Package

Crossroads is committed to bringing critical services to communities across the U.S. to improve access to treatment for over 26,500 patients.

J-18808-Ljbffr